Gavin MacBeath
Chief Executive Officer at TSCAN THERAPEUTICS, INC.
Net worth: 362 801 $ as of 2024-04-29
Gavin MacBeath active positions
Companies | Position | Start | End |
---|---|---|---|
TSCAN THERAPEUTICS, INC. | Director/Board Member | 2023-05-23 | - |
Chief Executive Officer | 2023-03-27 | - | |
Chief Operating Officer | 2022-05-31 | 2023-05-23 | |
Chief Tech/Sci/R&D Officer | 2018-11-30 | 2023-05-23 | |
Director of Finance/CFO | 2023-07-20 | 2024-01-28 |
Career history of Gavin MacBeath
Former positions of Gavin MacBeath
Companies | Position | Start | End |
---|---|---|---|
ABPRO CORPORATION | Chief Tech/Sci/R&D Officer | 2017-02-28 | 2018-06-30 |
MERRIMACK PHARMACEUTICALS, INC. | Founder | 1992-12-31 | 2017-08-31 |
Corporate Officer/Principal | 2011-07-12 | 2017-08-31 | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2002-06-30 | 2010-05-31 |
Training of Gavin MacBeath
University of Manitoba | Undergraduate Degree |
The Scripps Research Institute | Doctorate Degree |
Statistics
International
United States | 6 |
Canada | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
TSCAN THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Abpro Corp.
Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
- Stock Market
- Insiders
- Gavin MacBeath
- Experience